A detailed history of Captrust Financial Advisors transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 23,369 shares of IART stock, worth $579,784. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,369
Previous 17,914 30.45%
Holding current value
$579,784
Previous $635,000 7.09%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$23.14 - $34.72 $126,228 - $189,397
5,455 Added 30.45%
23,369 $680,000
Q1 2024

May 15, 2024

BUY
$33.4 - $45.2 $123,713 - $167,420
3,704 Added 26.07%
17,914 $635,000
Q4 2023

Feb 14, 2024

BUY
$34.21 - $44.59 $64,006 - $83,427
1,871 Added 15.16%
14,210 $618,000
Q3 2023

Nov 14, 2023

SELL
$37.8 - $45.97 $64,184 - $78,057
-1,698 Reduced 12.1%
12,339 $471,000
Q2 2023

Aug 14, 2023

BUY
$37.95 - $58.98 $123,868 - $192,510
3,264 Added 30.3%
14,037 $577,000
Q1 2023

May 15, 2023

SELL
$52.61 - $60.49 $5,892 - $6,774
-112 Reduced 1.03%
10,773 $618,000
Q4 2022

Feb 15, 2023

BUY
$42.17 - $58.6 $254,748 - $354,002
6,041 Added 124.71%
10,885 $610,000
Q3 2022

Nov 16, 2022

SELL
$42.28 - $57.17 $338 - $457
-8 Reduced 0.16%
4,844 $205,000
Q2 2022

Aug 23, 2022

SELL
$53.86 - $66.52 $24,021 - $29,667
-446 Reduced 8.42%
4,852 $262,000
Q2 2022

Aug 16, 2022

BUY
$53.86 - $66.52 $177,468 - $219,183
3,295 Added 164.5%
5,298 $286,000
Q1 2022

May 16, 2022

BUY
$62.86 - $69.24 $61,351 - $67,578
976 Added 95.03%
2,003 $129,000
Q4 2021

Feb 14, 2022

SELL
$62.47 - $73.25 $194,094 - $227,587
-3,107 Reduced 75.16%
1,027 $69,000
Q3 2021

Nov 16, 2021

BUY
$64.97 - $76.19 $17,217 - $20,190
265 Added 6.85%
4,134 $283,000
Q2 2021

Aug 16, 2021

SELL
$66.79 - $76.63 $3,940 - $4,521
-59 Reduced 1.5%
3,869 $264,000
Q1 2021

May 17, 2021

BUY
$62.63 - $71.15 $26,805 - $30,452
428 Added 12.23%
3,928 $271,000
Q4 2020

Feb 16, 2021

SELL
$43.31 - $66.55 $1,689 - $2,595
-39 Reduced 1.1%
3,500 $227,000
Q3 2020

Nov 17, 2020

BUY
$43.33 - $51.72 $49,872 - $59,529
1,151 Added 48.2%
3,539 $167,000
Q1 2020

May 15, 2020

BUY
$36.67 - $61.04 $87,567 - $145,763
2,388 New
2,388 $102,000
Q4 2019

Feb 14, 2020

SELL
$55.73 - $62.49 $113,967 - $127,792
-2,045 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$53.29 - $64.59 $6,128 - $7,427
-115 Reduced 5.32%
2,045 $123,000
Q2 2019

Aug 13, 2019

BUY
$46.45 - $55.85 $139 - $167
3 Added 0.14%
2,160 $121,000
Q1 2019

May 15, 2019

SELL
$42.97 - $57.33 $7,433 - $9,918
-173 Reduced 7.42%
2,157 $120,000
Q4 2018

Feb 13, 2019

BUY
$42.62 - $64.51 $30,132 - $45,608
707 Added 43.56%
2,330 $105,000
Q3 2018

Nov 15, 2018

BUY
$57.63 - $65.87 $749 - $856
13 Added 0.81%
1,623 $107,000
Q2 2018

Aug 13, 2018

BUY
$54.05 - $67.23 $10,755 - $13,378
199 Added 14.1%
1,610 $104,000
Q1 2018

May 15, 2018

SELL
$46.55 - $57.38 $21,785 - $26,853
-468 Reduced 24.91%
1,411 $76,000
Q4 2017

Feb 14, 2018

BUY
$46.22 - $51.77 $86,847 - $97,275
1,879
1,879 $90,000

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $2.07B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.